Appian and Luxoft Partner to Help Life Sciences Companies Transform Digitally
December 05 2017 - 7:30AM
Appian (NASDAQ:APPN), a leading low-code and business process
management platform provider, and Luxoft Holding, Inc (NYSE:LXFT),
a leading provider of software development services and innovative
IT solutions, today announced a global partnership to deliver
end-to-end, low-code solutions to Life Sciences companies around
the world.
Organizations are using software applications to
become agile across the business. The Appian platform helps
businesses streamline clinical operations, manage regulatory
compliance in real time, create immediate innovation throughout the
product lifecycle and accelerate speed to market.
"Speed to market and enabling life altering
treatments for patients faster and cheaper is a continuous
aspiration for all of us in the Life Sciences. Technology and
software are finally getting to the point where we can make a real
difference," says Evi Cohen, VP Global Pharma & Life Sciences
at Appian. "The right platform in the right hands will permit us to
move the needle here. This is why we are joining hands with
Luxoft."
The Appian low-code platform combines technical
software with a user interface simple enough for any employee to
use. This means companies can quickly build and deploy custom web
and mobile applications, increasing productivity while also saving
costs. Appian is used across a broad range of functions but a few
focus areas for life sciences include:
- Clinical Operations: Organizations leveraging
Appian have seen numerous benefits, including but not limited to;
reduced start-up cycle times by 60 percent, reduced cycle time
(end-to-end) by 32 percent, 50 percent reduction in cycle times
from RFP development to contract execution and reduced average
cycle times to 60 days.
- Regulatory Compliance: The Appian Platform has
advanced business process management capabilities that allow you to
automate, monitor, and control regulatory efforts during each step
of a product’s lifecycle, so applications and processes are
compliant throughout the entire process.
- GxP Compliance: Organizations in the cloud can
maintain GxP compliance and data integrity on the Appian Cloud by
ensuring audit trails, establishing service level agreements
(SLAs), and monitoring changes.
- Regulatory Information Management: The Appian
approach to Regulatory Information Management (RIM) has helped life
sciences organizations successfully manage a regulatory portfolio
of thousands of products across over 150 countries, comprising
global, regional, and local projects. Using Appian, organizations
can increase submission quality and achieve over 99 percent
regulatory compliance while decreasing system maintenance costs,
organizational complexity, and time to market.
Luxoft will leverage its IT integration
expertise, experience of providing IT services to major
pharmaceutical companies and 42 global delivery centers to help
companies implement these platforms.
“In areas such as drug discovery and regulatory
compliance, implementing solutions efficiently and right first time
is imperative,” said Sam Mantle, Healthcare & Life Sciences
Managing Director at Luxoft. “Appian’s business process management
capabilities integrated with professional services from Luxoft will
allow Life Sciences companies to better meet their business
challenges.”
To learn more about Appian and its work across
Life Sciences and Pharma, visit www.appian.com.
This press release includes forward-looking
statements. All statements contained in this press release other
than statements of historical facts, including, without limitation,
statements regarding market adoption of the Appian low-code
software platform, the results obtained by customers using the
Appian low-code software development platform, and the ability of
Appian to adhere to special standards and compliance requirements
are forward-looking statements. The words “anticipate,” believe,”
“continue,” “estimate,” “expect,” “intend,” “may,” “will” and
similar expressions are intended to identify forward-looking
statements. Appian has based these forward-looking statements
largely on its current expectations and projections about future
events and financial trends that Appian believes may affect its
financial condition, results of operations, business strategy,
short-term and long-term business operations and objectives and
financial needs. Those forward-looking statements are subject to a
number of risks and uncertainties, including, without limitation,
risks related to market adoption of low-code solutions to drive
digital transformation and market acceptance of the Appian
platform, risks related to Appian’s ability to meet its customers’
needs by scaling its business sufficiently quickly, continuing to
innovate and provide a useful platform, and providing satisfactory
deployment services, risks related to potential security breaches
and unauthorized access to Appian’s platform or customer data,
risks related to Appian’s ability to meet special standards or
requirements imposed by governmental and other highly regulated
entities, and the risks and uncertainties set forth in the “Risk
Factors” section of Appian’s Quarterly Report on Form 10-Q for the
quarter ended September 30, 2017 filed with the Securities and
Exchange Commission on November 2, 2017, and subsequent reports
that Appian has filed with the Securities and Exchange Commission.
Moreover, Appian operates in a very competitive and rapidly
changing environment. New risks emerge from time to time. It is not
possible for Appian’s management to predict all risks, nor can
Appian assess the impact of all factors on its business or the
extent to which any factor, or combination of factors, may cause
actual results to differ materially from those contained in any
forward-looking statements Appian may make. In light of these
risks, uncertainties and assumptions, Appian cannot guarantee
future results, levels of activity, performance, achievements or
events and circumstances reflected in the forward-looking
statements will occur. Appian is under no duty to update any of
these forward-looking statements after the date of this press
release to conform these statements to actual results or revised
expectations, except as required by law.
About Luxoft
Luxoft (NYSE:LXFT) is a global IT service
provider of innovative technology solutions that delivers
measurable business outcomes to multinational companies. Its
offerings encompass strategic consulting, custom software
development services, and digital solution engineering. Luxoft
enables companies to compete by leveraging its multi-industry
expertise in the financial services, automotive, communications,
and healthcare & life sciences sectors. Its managed delivery
model is underpinned by a highly-educated workforce, allowing the
Company to continuously innovate upwards on the technology stack to
meet evolving digital challenges.
Luxoft has more than 13,000 employees across 42
offices in 21 countries within five continents, with its operating
headquarters office in Zug, Switzerland. For more information,
please visit the website.
About Appian
Appian provides a leading low-code software
development platform that enables organizations to rapidly develop
powerful and unique applications. The applications created on
Appian’s platform help companies drive digital transformation and
competitive differentiation. For more information, visit
www.appian.com.
Media Inquiries
Patrick R. CorcoranGlobal Director, External
Relations212-964-9900 ext.
2453Press@luxoft.comTwitter: @Luxoft
Nicole Greggs Director, Media Relations +1
703.260.7868nicole.greggs@appian.com
Luxoft Holding, Inc. (NYSE:LXFT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Luxoft Holding, Inc. (NYSE:LXFT)
Historical Stock Chart
From Apr 2023 to Apr 2024